Zhejiang Taimei Medical Technology Co., Ltd.
Zhejiang Taimei Medical Technology Co., Ltd. (HKSE: 2576) is trading at HK$5.00, about ₹61 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET. Indian residents can buy Zhejiang Taimei Medical Technology from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$4.80
Today's high
HK$5.00
52 week low
HK$3.61
52 week high
HK$7.50
2576 opened at HK$5.00, closed previously at HK$5.00, and has traded between HK$3.61 and HK$7.50 over the past 52 weeks.
About
Zhejiang Taimei Medical Technology Co., Ltd., established in 2013 and based in Jiaxing, China, specializes in delivering sophisticated digital operational platforms specifically designed for the biopharmaceutical industry across the country. The company's core offering is TrialOS, a comprehensive digital collaboration platform that seamlessly integrates all participants throughout the drug development and research lifecycle. This ecosystem effectively links hospitals, pharmaceutical firms, external service providers, regulatory bodies, and patients, among other key industry stakeholders. Its extensive portfolio of software solutions caters to various critical aspects of clinical research and drug development. For streamlining clinical trial operations, Taimei Medical provides tools like eCooperate, which optimizes management systems and leverages big data for informed decision-making. Other related offerings include eArchives for managing master files, eCollect for electronic data capture, eCollege for training administration, eQuality for electronic audit processes, and eBalance for interactive web-based responses. Innovations such as eVisit Patient Reported Outcomes are designed to enhance patient data input and accuracy, while eTime supports project time management, and eImage facilitates medical image interpretation. Furthermore, the company supplies specialized software tailored for hospitals and Good Clinical Practice (GCP) sites. These include eTrial for managing Phase I wards, eSite and NomenCTMS for comprehensive clinical trial management at study sites, and intelligent platforms like GCP-X and Intelligent Investigator. Solutions such as eScreening assist with subject information management and deduplication, while IIT-EDC and the Investigator-Initiated Clinical Trial Management System support investigator-initiated studies and their associated data management. In the crucial domain of drug safety, the company offers robust pharmacovigilance software solutions. This includes both global and intelligent eSafety systems, alongside the SAE Manager for efficient communication and management of critical safety data during clinical trials. Complementing these, Zhejiang Taimei also develops marketing software and a variety of other digital innovation solutions.
Key statistics
Avg. volume
854.36K
Market cap
HK$2.82B
P/E Ratio
-36.96
Price-to-sales ratio
4.53
Enterprise value
CN¥2.02B
Free cash flow yield
0.28%
Debt-to-equity ratio
0.08
Return on equity
-5.91%
ROIC
-7.81%
Beta
0.01
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥499.28M
Earnings per share
-CN¥0.07
Free cash flow
-CN¥43.15M
Net profit margin
-12.25%
Gross margin
44.20%
EBITDA
-CN¥29.11M
Revenue growth
-9.41%
Similar securities
This is not an investment recommendation
How to buy Zhejiang Taimei Medical Technology from India
Indian residents can buy Zhejiang Taimei Medical Technology shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Zhejiang Taimei Medical Technology and place an order
Find Zhejiang Taimei Medical Technology by name or by its ticker, 2576, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Zhejiang Taimei Medical Technology trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Zhejiang Taimei Medical Technology position in HKD and INR. Zhejiang Taimei Medical Technology pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Zhejiang Taimei Medical Technology from India
Trading and taxes when buying Zhejiang Taimei Medical Technology from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneZhejiang Taimei Medical Technology does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Zhejiang Taimei Medical Technology stock?
Yes. Zhejiang Taimei Medical Technology (2576) has been listed on the Hong Kong Stock Exchange since 2024, in the Software - Application industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Zhejiang Taimei Medical Technology share cost in rupees?
One Zhejiang Taimei Medical Technology share is HK$5.00 — about ₹61 at an HKD/INR rate of 12.23 on 25 Sep 2026. Both the Zhejiang Taimei Medical Technology price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Zhejiang Taimei Medical Technology from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Zhejiang Taimei Medical Technology?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Zhejiang Taimei Medical Technology shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Zhejiang Taimei Medical Technology price. Paasa issues a capital-gains statement for your return.
Does Zhejiang Taimei Medical Technology pay a dividend?
No. Zhejiang Taimei Medical Technology does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Zhejiang Taimei Medical Technology from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Zhejiang Taimei Medical Technology a Hong Kong SAR China company, and does that change how it is taxed?
Zhejiang Taimei Medical Technology trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Zhejiang Taimei Medical Technology trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Zhejiang Taimei Medical Technology shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Zhejiang Taimei Medical Technology holding, its cost and its closing value.
How do I sell Zhejiang Taimei Medical Technology and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.